Marianne Delville

Title: Marianne Delville: Innovator in Autoimmunity Research

Introduction: Marianne Delville is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the study and treatment of autoimmune conditions. With a background in research, she has worked at esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Cité.

Latest Patent Applications: Marianne Delville has been involved in several innovative research projects, leading to the following latest patent applications:

1. **Methods of Inducing or Restoring Immune Tolerance** - This application addresses severe autoimmune conditions of hereditary origin, such as APECED and IPEX syndrome. The inventors have developed innovative strategies using regulatory T cells to treat Scurfy autoimmune syndrome. The optimized protocol includes administering cyclophosphamide, engrafting Treg cells, and administering IL-2 to patients in need.

2. **Recombinant Vectors Suitable for the Treatment of IPEX Syndrome** - This application focuses on IPEX syndrome, a primary immunodeficiency caused by mutations in the FOXP3 gene. The research aims to restore the repertoire of Treg cells through T cell gene therapy. The inventors compared various lentiviral constructs and selected one that demonstrated remarkable efficiency for preparing Treg cells.

Conclusion: Marianne Delville's work in the field of immunology showcases her dedication to advancing treatments for autoimmune diseases. Her innovative approaches and research contributions are paving the way for potential breakthroughs in the treatment of these complex conditions.